Download PDF
1 / Pages

Other users also viewed these articles

Renal potassium management in chronic kidney disease: Differences between patients with or without hyperkalemia Fernando Caravaca-Fontán; Julian Valladares; Rosa Díaz-Campillejo; Sergio Barroso; Enrique Luna; Francisco Caravaca;
Nefrologia (English Version). 2020;40:152-9
Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM) José-Vicente Torregrosa; Jordi Bover; Mariano Rodríguez Portillo; Emilio González Parra; María Dolores Arenas; Francisco Caravaca; María-Luisa González Casaus; Alejandro Martín-Malo; Juan Francisco Navarro-González; Víctor Lorenzo; Pablo Molina; Minerva Rodríguez; Jorge Cannata Andia;
Nefrologia (English Version). 2023;43 Supl 1:1-36
Successful correction of metabolic acidosis is difficult to achieve inchronic kidney disease Fernando Caravaca-Fontán; Rosa Díaz-Campillejo; Julián Valladares; Cristina López Arnaldo; Sergio Barroso; Enrique Luna; Francisco Caravaca;
Nefrologia (English Version). 2020;40:328-35